Logo image of AXTI

AXT INC (AXTI) Stock Fundamental Analysis

NASDAQ:AXTI - Nasdaq - US00246W1036 - Common Stock - Currency: USD

2.14  +0.07 (+3.38%)

After market: 2.1801 +0.04 (+1.87%)

Fundamental Rating

1

AXTI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI may be in some trouble as it scores bad on both profitability and health. AXTI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AXTI had negative earnings in the past year.
AXTI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: AXTI reported negative operating cash flow in multiple years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

AXTI has a worse Return On Assets (-5.55%) than 68.18% of its industry peers.
AXTI has a worse Return On Equity (-10.01%) than 68.18% of its industry peers.
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROIC N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

AXTI has a Gross Margin of 17.18%. This is amonst the worse of the industry: AXTI underperforms 82.73% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AXTI has been increased compared to 1 year ago.
AXTI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AXTI is higher compared to a year ago.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that AXTI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.50, AXTI is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
AXTI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.31, AXTI is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC10.55%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

AXTI has a Current Ratio of 1.99. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
AXTI has a Current ratio of 1.99. This is in the lower half of the industry: AXTI underperforms 72.73% of its industry peers.
AXTI has a Quick Ratio of 1.99. This is a bad value and indicates that AXTI is not financially healthy enough and could expect problems in meeting its short term obligations.
AXTI has a worse Quick ratio (0.92) than 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 0.92
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

AXTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.38%.
The Revenue has decreased by -2.64% in the past year.
Measured over the past years, AXTI shows a small growth in Revenue. The Revenue has been growing by 3.59% on average per year.
EPS 1Y (TTM)-59.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-35.63%

3.2 Future

AXTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.20% yearly.
Based on estimates for the next years, AXTI will show a small growth in Revenue. The Revenue will grow by 7.62% on average per year.
EPS Next Y-107.65%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.27%
Revenue Next 2Y7.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXTI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AXTI's earnings are expected to grow with 35.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.2%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXT INC

NASDAQ:AXTI (8/19/2025, 5:01:31 PM)

After market: 2.1801 +0.04 (+1.87%)

2.14

+0.07 (+3.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners34.68%
Inst Owner Change-12.66%
Ins Owners2.46%
Ins Owner Change12.77%
Market Cap97.58M
Analysts83.64
Price Target3.9 (82.24%)
Short Float %1.44%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.8%
Min EPS beat(2)-130.68%
Max EPS beat(2)-42.91%
EPS beat(4)2
Avg EPS beat(4)-29.68%
Min EPS beat(4)-130.68%
Max EPS beat(4)32.39%
EPS beat(8)5
Avg EPS beat(8)-5.53%
EPS beat(12)9
Avg EPS beat(12)11.41%
EPS beat(16)12
Avg EPS beat(16)11.13%
Revenue beat(2)1
Avg Revenue beat(2)1.4%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)2.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-10.79%
Max Revenue beat(4)4.02%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)4
Avg Revenue beat(12)-1.81%
Revenue beat(16)6
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.78%
PT rev (3m)-0.78%
EPS NQ rev (1m)-4.07%
EPS NQ rev (3m)-19.96%
EPS NY rev (1m)0%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)-2.47%
Revenue NQ rev (3m)-5.16%
Revenue NY rev (1m)-2.76%
Revenue NY rev (3m)-4.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS2.11
BVpS4.06
TBVpS4.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.18%
FCFM N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.97%
Cap/Sales 1.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 0.92
Altman-Z 0.5
F-Score3
WACC10.55%
ROIC/WACCN/A
Cap/Depr(3y)178.33%
Cap/Depr(5y)282.49%
Cap/Sales(3y)13.27%
Cap/Sales(5y)16.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-107.65%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-35.63%
Revenue Next Year-10.27%
Revenue Next 2Y7.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-378.56%
OCF growth 3YN/A
OCF growth 5YN/A